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Abstract
We have identified LmaPA2G4, a homolog of the human proliferation-associated 2G4 protein (also termed Ebp1), in a
phosphoproteomic screening. Multiple sequence alignment and cluster analysis revealed that LmaPA2G4 is a non-peptidase
member of the M24 family of metallopeptidases. This pseudoenzyme is structurally related to methionine aminopeptidases. A
null mutant system based on negative selection allowed us to demonstrate that LmaPA2G4 is an essential gene in Leishmania
major. Over-expression of LmaPA2G4 did not alter cell morphology or the ability to differentiate into metacyclic and amastigote
stages. Interestingly, the over-expression affected cell proliferation and virulence in mouse footpad analysis. LmaPA2G4 binds a
synthetic double-stranded RNA polyriboinosinic polyribocytidylic acid [poly(I:C)] as shown in an electrophoretic mobility shift
assay (EMSA). Quantitative proteomics revealed that the over-expression of LmaPA2G4 led to accumulation of factors involved in
translation initiation and elongation. Significantly, we found a strong reduction of de novo protein biosynthesis in transgenic
parasites using a non-radioactive metabolic labeling assay. In conclusion, LmaPA2G4 is an essential gene and is potentially
implicated in fundamental biological mechanisms, such as translation, making it an attractive target for therapeutic intervention.
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Introduction
Protozoan parasites of the genus Leishmania are the causative
agents of leishmaniasis, a disease that is characterized by a
spectrum of clinical manifestations ranging from ulcerative skin
lesions to fatal visceral infections [1]. Leishmaniasis is a poverty-
related disease and is associated with malnutrition, displacement,
poor housing, illiteracy, gender discrimination, weakness of the
immune system and lack of resources [2]. Leishmaniasis is further
compromised by the emergence of co-infection with human
immunodeficiency virus (HIV) in endemic areas [3]. Globally,
there are an estimated 1.5–2 million new cases of leishmaniasis
and 70,000 deaths each year, and 350 million people are at risk of
infection and disease [4]. Due to the absence of vaccination,
chemotherapy, together with vector control, remains one of the
most important elements in the control of leishmaniasis. Current
anti-leishmanial drugs include pentavalent antimony, amphoter-
icin B and miltefosine; most are toxic and expensive. To date, no
successful vaccine exists and the few anti-leishmanial drugs
mentioned risk becoming ineffective due to emerging resistances
[5,6]. Therefore, new drugs are urgently needed [7].
During the infectious cycle, Leishmania differentiates from the
extracellular promastigote to the intracellular amastigote form.
Flagellated promastigotes develop in the midgut of sandflies, and
following infection in humans, differentiate to intracellular
amastigotes that multiply inside the macrophage lysosome [8].
This differentiation is triggered by environmental signals,
mainly acidic pH and high temperature in the mammalian
host [9].
Signal transduction pathways often relay these environmental
stimuli through reversible phosphorylation, ultimately leading to
changes in protein activity, interaction and expression profiles [10].
Mitogen-activated protein kinases (MAPKs) are conserved virtually
across all eukaryotic organisms. To gain insight into the MAPK
pathway in Leishmania we performed comparative phosphoproteomics
of MPK7 [11] and WT parasites with the objective of characterizing
putative substrates of this kinase. As part of the screening we identified
LmaPA2G4, a homolog of human proliferation-associated 2G4
(PA2G4, also termed Ebp1) [12]. PA2G4 proteins are highly
conserved in eukaryotes and are involved in the regulation of cell
growth and differentiation. The human member of this family, ErbB3
binding protein 1 (Ebp1), is ubiquitously expressed and localizes in
both the nucleus and cytoplasm [13]. The protein binds structured
RNAs and was suggested to be involved in linking ribosome
biosynthesis and cell proliferation [14]. Here we show that
LmaPA2G4 is an essential gene in L. major. The over-expression of
LmaPA2G4 results in accumulation of intermediates of translation
initiation and ultimately leads to growth and virulence defects.
Materials and Methods
Ethics statement
The University of Notre Dame is credited through the Animal
Welfare Assurance (#A3093-01). All animal studies were conducted
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according to the Institutional Animal Care and Use Committee
(IACUC) guidelines. The protocol for the infection of mice with
Leishmania was approved by the University’s IACUC (October 16,
2012, protocol #15-047).
Parasite culture
Leishmania major strain Friedlin V1 (MHOM/JL/80/Friedlin)
was cultured in M199 medium supplemented with 10% FBS at
26uC and pH 7.4 [15]. L. donovani strain 1S2D (MHOM/SD/62/
1S-CL2D) was grown in M199 supplemented with 10% FBS and
axenic amastigotes were differentiated as described previously
[16]. For some experiments L. major metacyclic promastigotes were
enriched by agglutination [17]. Briefly, cells were incubated for
30 min at RT with 50 mg/ml peanut agglutinin in M199 without
serum, agglutinated parasites were removed by centrifugation and
metacyclic parasites were recovered from the supernatant.
Bioinformatics
L. major CAJ07101 (gi|68126048) was used as an initial query
for PSI-BLAST and after four cycles results with significant E-
values (,10e26) were selected. Sequences corresponding to
putative aminopeptidase proteins from the sequenced genomes
of H. sapiens, L. major, L. infantum, L. braziliensis, L. donovani, T. brucei,
T. vivax, T. cruzi and T. congolense were retrieved using TriTrypDB
and UniProt databases; (http://tritrypdb.org/tritrypdb/) and
(www.uniprot.org). Sequences were aligned with Clustal X (v
2.0). Alignments were converted to MEGA compatible files and
fed into the MEGA5.2 software package. A Neighbor-Joining tree
was computed with 500 bootstrap replicates.
Molecular constructs and sequencing
In order to generate null mutants, a 901 bp region in the 59
untranslated region (UTR) upstream of LmaPA2G4 was amplified
with the primers 59-ACCGGTACCCAATCATGGCCCACC-
GAAGG- 39 (KpnI) and 59-CGCCCCGGG/CTCGAGTTTTT-
TTGGGTGGGTGGC-39 (SmaI or XhoI). A 903 bp fragment in
the 39UTR was amplified with primers 59-ACCCTCGAG/
GGATCCACGGCCGTGGCATCCGTG-39 (XhoI or BamHI)
and 59-CGCGGTACCCACGATGGGCAGAACGCC- 39 (KpnI).
Reactions were performed in a total volume of 50 ml containing
LongAmp high fidelity Taq- DNA polymerase (New England
Biolabs) following the manufacturer’s recommendation. Products
were cloned into pGEM-T and pGEM-T Easy vectors (Promega)
to create pGEM-T-59UTR-39UTR. A 2.8 kb SmaI-XhoI fragment
from pX63HYG containing the hygromycin B (HYG B) gene and
a 2.5 kb XhoI-BamHI fragment from PX63PAC including the
puromycin (PAC) were ligated between 59UTR and 39UTR to
generate the two targeting constructs. Constructs were linearized
with KpnI and dephosphorylated. The LmaPA2G4 homolog
(CAJ07101) was PCR amplified from genomic DNA of L. major
FVI using the primers 59-ACCAGATCTATGTCAAAGAACG-
CTGAC- 39(BglII) and 5-GCGAGATCTCTACTTCGCGCGC-
TTCTT- 39(BglII). Purified PCR products were cloned into
pGEM-T EasyVector (Promega). N-terminal GFP-PA2G4 fusion
and pXNG-PA2G4 were obtained by inserting the 1.1 kb BglII
fragment from pGEM-T into the respective site of pXG-GFP+2
[18] and pXNG [19]. F1, R1 primer pair 59- CATCAATATTT-
CATGCGC-39 and 59-CGTGTCCTCCTCTTCTTC- 39; F2,
R1 59- GGTAGTGTCGCGTGTTGG-39; F1, R2 59-CTGCAT-
CAGGTCGGAGACGC-39 and F1, R3 59-GGGGTCAGGG-
GCGTGGGTCAG-39 were used to corroborate the absence of
LmaPA2G4 ORF in the null mutant lines. LmaPA2G4 was PCR
amplified and cloned into episomal vector pLEXSY (Jena
Bioscience), and parasites were selected in 75 mg/mL hygromycin
B (Sigma). Parasites transfected with the empty vector, pXG-
GFP+2 and pLEXSY were used as mock controls. Null mutants
and episomal transfectants were established by electroporation as
previously described [20,21].
RT-PCR analysis
Total RNA was isolated from L. major and L. donovani WT and
transgenic parasites with Trizol reagent (Life Technologies Inc.,
NY) using RNase-free plastic supplies. cDNA was amplified using
M-MLV Reverse Transcriptase (Sigma) and oligo d(T)15 (Pro-
mega) following manufacturer’s recommendations. PCR was
carried out with LongAmp high fidelity Taq- DNA polymerase
(New England Biolabs) using LmaPA2G4 specific primers 59-
CCACGTGGACGGCTACTGCGCCG-39 and 59- CTTCCTT-
TTCGAAGAGAATAGGG-39 and GAPDH primers 59- CGAC-
GACGGCAAAGCAGAAG-3; and 59- TCAGCGCCACACCG-
TTGAAG-39. All RNA samples were treated with DNA-free
(Ambion, Inc., TX) to remove contaminating genomic DNA. Each
RT-PCR product was analyzed by gel electrophoresis using 1%
agarose gels and band intensity analyzed with ImageQuant TL
software (GE Healthcare).
Confocal microscopy
Live L. major promastigotes over-expressing GFP-PA2G4 were
immobilized on poly (L-lysine)-coated 35 mm glass bottom dishes
(MatTek Corporation, USA) and counterstained with 1 mg/mL
NucBlue Live Cell stain (Hoechst 33342) (Molecular Probes).
Fluorescent imaging was performed using a spinning disk confocal
Revolution (Andor Technology) and a 636 oil immersion
objective. Image acquisition was done using AndorIQ software
(Andor Technology) and images processed with ImageJ software
(NIH, USA).
Mouse infections
Virulence studies were performed as previously described [11].
Briefly, groups of five female BALB/c mice (Charles River) were
injected in the footpad with 105 metacyclic promastigotes from
Author Summary
Leishmaniasis is a disease caused by protozoan parasites of
the genus Leishmania. Its clinical manifestations are
widespread, ranging from ulcerative skin lesions to life-
threatening visceral infections. Approximately 1.5–2 mil-
lion new cases of leishmaniasis are reported each year with
an estimated 70,000 deaths. During the infectious cycle,
Leishmania differentiates from the extracellular promasti-
gote to the intracellular pathogenic amastigote form.
Differentiation is triggered by environmental signals within
the mammalian host, namely acidic pH and high temper-
ature. Due to the absence of vaccination, chemotherapy,
together with vector control, remains one of the most
important elements in the control of leishmaniasis. Current
anti-leishmanial drugs include pentavalent antimony,
amphotericin B and miltefosine; most are toxic, expensive
and risk becoming ineffective due to emerging resistance.
Therefore, new drugs are urgently needed. LmaPA2G4 is a
homolog of human proliferation-associated 2G4 protein
(PA2G4, also termed Ebp1). We show that it is an essential
gene in L. major and a gain-of-function approach allowed
us to implicate LmaPA2G4 in translation and subsequent
protein synthesis reduction, growth defects and virulence
attenuation. This work highlights the essential role of
LmaPA2G4 in the biology of the parasite and thus makes it
an attractive target for drug development.
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GFP-PA2G4, cured GFP-PA2G4 and mock control. Lesions were
followed weekly by measuring the thickness of footpads with a
Vernier caliper.
Western blot analysis
Crude cell lysates were separated in 4–12% Bis-Tris NuPAGE
gels (Life), and electro-blotted onto PVDF membranes (Pierce).
Proteins were revealed using the following primary antibodies:
mouse monoclonals anti-A2 (Abcam) and anti-GFP-HRP (Milte-
nyi Biotec), mouse monoclonal anti-tubulin (Sigma), and anti-
rabbit or anti-mouse HRP-conjugated secondary antibodies
(Pierce).
In vitro kinase assay
20 mL of immuno-complexes (GFPK7; transgenic parasites
over-expressing an active MPK7) were incubated in a Thermo-
mixer R (Eppendorff) for 30 min at 30uC and 1000 rpm in a
50 mL reaction mixture (Millipore) containing 5 mg myelin basic
protein (MBP) substrate (positive control) or recombinant substrate
and 10 mCi [c-32P] ATP (3000 Ci/mmol). Reactions were
terminated by heating the samples for 10 min at 98uC in
NuPAGE sample buffer and reducing agent (Life). 30 mL of the
reaction were separated by SDS-PAGE. The gel was Coomassie-
stained, fixed, dried and analyzed by autoradiography.
Sample preparation and labeling for 2D- DIGE
Protein extracts from logarithmic L. major WT, GFP-PA2G4
and stationary GFPK7 promastigotes were differentially labelled
with the spectrally resolvable Cy3 and Cy5 as previously described
[21]. A pool of extracts was labelled with Cy2 for normalization
purposes, following the manufacturer’s recommendations (GE
Healthcare). Phosphoproteins were enriched with affinity IMAC
columns (Qiagen) as previously described [22]. Following label-
ling, proteins were precipitated using a 2-D Clean-Up kit (GE
Healthcare), allowing for quantitative precipitation and removal of
interfering substances, such as detergents, salts, lipids, phenolics,
and nucleic acids.
Electrophoretic Mobility Shift Assays
Synthetic double stranded RNA Poly (I:C) (Sigma) was labeled
with Label IT Cy5 labeling kit (Mirus). Briefly, 5 mg of RNA was
incubated at a 1:1 (v:w) ratio of Label IT Cy5 reagent to nucleic
acid. 40 ng of labeled Poly(I:C) was incubated with 20 ng GFP-
PA2G4 fusion protein in binding buffer (50 mM Tris pH 7.4,
0.5 mM EDTA, and 150 mM NaCl) at room temperature for
45 min. GFP-PA2G4 was immunoprecipitated with anti-GFP
magnetic beads as previously described [20]. An aliquot of gel
loading buffer (0.25% bromophenol blue, 0.25% xylene cyanol,
50% glycerol) was added to the reaction mixture and resolved on
10% non-denaturing polyacrylamide gels in 16TBE. Gels were
scanned on a Typhoon FLA 9500 Imager (GE Healthcare) using
633/670 nm for Cy5 filter and 489/508 nm for GFP filter.
Isoelectric focusing (IEF) and two-dimensional gel
electrophoresis (2D)
IEF of 100 or 120 mg of protein was carried out using an
EttanIPGphor 3 System (GE Healthcare) at 20uC with 11 and
13 cm non-linear DryStrip (pH 4–7). Strips were passively
rehydrated overnight at room temperature in rehydration solution
(GE Healthcare) containing 0.5% IPG buffer 4–7 and the sample.
The IEF maximum current setting was 50 mA/strip. The following
conditions were programmed for IEF: 100 V gradient step for 5 h,
300 V gradient step for 5 h, 1000 V gradient step for 2 h, 6000 V
gradient step for 8 h and 6000 V for 5 h (60550 Vh). Following
IEF, strips were equilibrated in two different solutions for 15 min
each (6 M urea, 75 mMTris/HCl pH 8.8, 29.3% glycerol, 4%
SDS, 0.002% bromophenol blue) supplemented with 65 mM
DTT and 13.5 mM iodoacetamide, respectively. The strips were
transferred to SDS polyacrylamide gels and sealed with 0.5%
agarose in 25 mMTris-base, 0.19 M glycine, 0.2% SDS, 0.01%
bromophenol blue. Electrophoresis was carried out in an SE 600
Ruby cooled electrophoresis system (GE Healthcare) using 12.5%
SDS-PAGE gels and two-step runs (1 W/gel for 15 min and 7 W/
gel for 5 h).
Staining procedures and image analysis
After electrophoresis, gels were scanned on a Typhoon FLA
9500 Imager (GE Healthcare) using 488/520 nm for Cy2, 532/
580 nm for Cy3, 633/670 nm for Cy5 and 100 mm as pixel size.
Gel images were normalized by adjusting PMT voltage to obtain
appropriate pixel value without any saturation. Images were
analyzed with Decyder v. 6.5 (GE Healthcare) and Delta2D v.4.3
software (Decodon). Gels were matched or warped and spots
detected across all images. A 2-fold difference in abundance, with
p-values,0.05, was considered significant for the expression
profiles. Polyacrylamide gels were then fixed in 50% methanol
and 7% acetic acid and stained using SYPRO Ruby total protein
gel stain (Life). Spots of interest were manually excised from gels
using a blue-light transilluminator (Life).
Protein identification
The gel spots were subjected to reduction with 55 mM dithiothre-
itol (Sigma-Aldrich) in 25 mM ammonium bicarbonate (Fisher
Scientific) at 56uC for 1 hour followed by alkylation with 100 mM
iodoacetamide (Sigma-Aldrich) in 25 mM ammonium bicarbonate at
room temperature in the dark for 45 min. The spots were washed
with 25 mM ammonium bicarbonate for 10 min followed by two
consecutive washes with 25 mM ammonium bicarbonate in 50/50
acetonitrile:water for 5 min, each. The spots were placed in a vacuum
concentrator to dry completely before the addition of 12.5 ng trypsin
gold (Promega) to each gel spot. The spots were kept at 4uC for
30 min to swell and then were incubated at 37uC overnight.
Following trypsin digestion, the supernatant was collected. Peptides
were further extracted from the gel spots with two consecutive
additions of 50% acetonitrile/45% water/5% formic acid to the spots
followed by 30 min of vortexing. The two sets of extracts were
combined with the supernatant from each gel spot and then vacuum
concentrated to 10 mL. Each concentrated digest was desalted with a
C18 Ziptip (EMD Millipore) according to the manufacturer
instructions. The desalted digests were then dried down in a vacuum
concentrator and reconstituted in 10 mL of 0.1% TFA in water. A
2 mL aliquot of each gel digest was injected onto a nanoAcquity
UPLC (Waters Corporation) with a BEH300 C18 100 mm6100 mm
column (Waters Corporation) with 1.7 mm particle size. A gradient of
0.1% formic acid in water (A) and 0.1% formic acid in acetonitrile (B)
was performed starting with 2% B held for 6 min and then ramping
to 40% B to 40 min and 90% B to 43 min. The column was washed
with 90% B for 7 min and then re-equilibrated with 98% A: 2% B.
The nanoAcquity was coupled to a LTQ Orbitrap Velos mass
spectrometer (Thermo Corporation) for data dependent scans of the
digested samples in which the top nine abundant ions in a scan were
selected for CID fragmentation. The UPLC-MS/MS chromatograms
and spectra were analyzed using Xcalibur software (Thermo), and the
extracted data were searched against the L. major custom database via
Mascot and/or Protein Pilot. Search criteria included a global
modification of carbamidomethylation on the cysteines. Proteins
identified had less than a 1% false discovery rate.
Essential Genes as Drug Targets in Leishmania
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Metabolic labeling
The metabolic labeling of de novo synthetized proteins was
conducted using the non-radioactive assay Click-iT AHA kit and
Click-iT Cell Reaction Buffer Kit (Life) following manufacturer’s
guidelines with minor modifications. Briefly, 26108 mid-log phase
WT and GFP-PA2G4 L. major and L. donovani promastigotes as well as
GFP-PA2G4 L. donovani amastigotes were initially incubated for
30 min at 27uC in 2 mL methionine-free RPMI medium supple-
mented with 10% FBS in order to deplete methionine reserves.
Metabolic labeling was performed for 2 h at 27uC in presence of
50 mM azidohomoalanine (AHA). A culture of L. major treated for 2 h
with 100 mg/mL cycloheximide, an inhibitor of protein biosynthesis,
was included as a positive control. After labeling, cells were harvested
and lysed and 50 mL of each sample was employed to perform the
Click reaction with TAMRA. Proteins were precipitated, resolubi-
lized in 1D gel electrophoresis sample loading buffer and heated for
10 min at 70uC and subsequently resolved in a precast polyacryl-
amide gel (NuPAGE Novex 4–12% Bis-Tris gels, Life). Gel was
visualized in a Typhoon FLA 9500 (GE Healthcare) and analyzed
with ImageQuant TL software (GE Healthcare). After imaging the
gel with TAMRA-labeled samples, the gel was fixed and stained with
SYPRO Ruby in order to assess total protein content. Statistical




We have previously shown that L. major MPK7 is implicated in
parasite growth control, including the pathogenic amastigote stage
[11]. The overexpression of an active MPK7 (GFPK7 transgenic
parasites overexpressing MPK7) led to defects in cell cycle and,
ultimately, attenuated virulence in a mouse model. In order to
identify potential downstream targets of MPK7 we performed
comparative 2D-DIGE of phosphoproteins isolated from four
independent stationary cultures of L. major wild type (WT) and
GFPK7 promastigotes. MPK7 shows increased activity at
stationary phase [20]. Phosphoproteins were isolated by immobi-
lized metal affinity chromatography (IMAC) and differentially
labeled with CyDye fluors (GE Healthcare) as detailed in Material
and Methods. Phosphoproteins were separated by 2DE on pH 4–
7 IPG immobiline strips and SDS-PAGE. Images were analyzed
with DeCyder 6.5 software (GE Healthcare). Up-regulation of
spots more than 2-fold in GFPK7, with p-values,0.05 were
considered significant. Spot ID 207 was over-represented in
GFPK7 (2.97 fold change and p = 0.00056) and excised from the
gel and analyzed by MS/MS (Fig. 1). LmjF19.0160 (Tritryp gene
ID) is a putative aminopeptidase with a predicted MW of 43 kDa.
Recombinant LmjF19.0160 was not phosphorylated in vitro by
active GFPK7 using an in vitro kinase assay (Fig. S1). Phospho-
transferase activity of recombinant GFPK7 was assessed by
phosphorylation of MBP. Given the fact that LmjF19.0160 was
enriched with an IMAC (phospho-specific) column, we are
attempting to characterize the putative phosphorylation sites, with
the objective of performing site-directed mutagenesis.
Bioinformatics analysis of L. major LmjF19.0160
LmjF19.0160 belongs to the clan MG, family M24 of
metallopeptidases according to the classification of MEROPS
database [23]. Family M24 is further divided into subfamilies
M24A and B. Typical members of subfamily M24A are methionyl
aminopeptidases type I and II (METAP1 and 2). These peptidases
are essential for the removal of the initiating methionine of many
proteins [24]. We investigated the relationship between human
and trypanosomatid members of the M24 family of metallopepti-
dases by multiple alignment and cluster analysis. LmjF19.0160
(protein ID gi|68126048) was used as an initial query for PSI-
BLAST against the sequenced genomes of H. sapiens, L. major, L.
infantum, L. braziliensis, L. donovani, T. brucei, T. cruzi, T. vivax and T.
congolense. Homologs of human METAP1 and 2 are found in all
trypanosomatids as shown by the clustering tree (Fig. 2). Bootstrap
values support the existence of METAP1 and 2 subclasses among
Leishmania and Trypanosoma. Interestingly, LmjF19.0160 clusters
with homologs of the human proliferation-associated protein 2G4
(PA2G4) [25]. These are non-peptidase proteins which possess the
‘‘pita-bread’’ fold typical of methionyl aminopeptidases, however
they lack metal cofactors and peptidase activity [26].
RT-PCR analysis
Although the genome of Leishmania seems to be constitutively
expressed [27], between 6% and 9% of the genes display
significant expression profiles. Therefore, we analyzed the
transcript levels of LmaPA2G4 by semi-quantitative RT-PCR.
Total RNA was isolated from L. major logarithmic and metacyclic
parasites. Peanut agglutination was used to enrich metacyclics in
stationary cultures [28]. For L. donovani we used host-free
amastigotes as previously described [16]. GAPDH was used as a
housekeeping gene for semi-quantification purposes. As judged by
the LmaPA2G4/GAPDH ratio, there are not significant differ-
ences in the expression levels across different life stages (Fig. S2).
Figure 1. 2D-DIGE quantitative phosphoproteomics analysis of
GFPK7. An enlarged region of the 2D-DIGE gels showing Cy3-labeled
WT stationary promastigotes and Cy5-labeled stationary GFPK7
promastigotes is presented. Spot ID 207 (white arrow) was over-
represented in GFPK7. In the lower panel, a graphical representation of
the BVA (Biological Variation Analysis) module of Decyder software (GE
Healthcare) with statistics for spot ID 207 (2.97 fold and p= 0.00056).
The spot was analyzed by mass spectrometry and identified as
LmjF19.0160, a putative aminopeptidase.
doi:10.1371/journal.pntd.0002646.g001
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Figure 2. Bioinformatics analysis of L. major LmjF19.0160. Relationship between human and trypanosomatid members of the M24A subfamily
of metallopeptidases was analyzed by multiple alignment and cluster analysis using Clustal X. This subfamily comprises homologs of methionyl
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Loss-of-function studies in LmaPA2G4
In order to gain insight into the putative function of PA2G4 in
Leishmania we designed a loss-of-function strategy. Leishmania are
diploid parasites and two rounds of targeted replacement with a drug-
resistance marker are necessary. Unsuccessful attempts to replace the
two PA2G4 alleles with resistance markers, to create a homozygous
KO, suggested that LmaPA2G4 may be an essential gene. To
demonstrate the essentiality of LmaPA2G4 we used a genetic method
based on negative selection [19] to guard against the potential lethal
phenotype. Both LmaPA2G4 alleles could be removed by homol-
ogous recombination in the presence of an episome expressing
LmaPA2G4 (pXNG-PA2G4) (Fig. 3A). The loss of endogenous
LmaPA2G4 in the null mutants was confirmed in two independent
homozygous lines by PCR (Fig. 3B). As expected, only the episomal
copy of LmaPA2G4 is present. The episome pXNG [19] carries a
negative selectable thymidine kinase (TK), a fluorescent protein
(GFP) and a resistance marker (SAT). TK renders the parasites
susceptible to ganciclovir (GCV). PXNG-PA2G4/WT parasites were
selected and grown in the presence of 250 mg/mL nourseothricin
(SAT) and the GFP intensity was analyzed by flow cytometry. After
negative selection with the addition to the culture of 50 mg/mL GCV
during three passages, a dramatic shift in GFP fluorescence was
observed (Fig. 3C, upper panel). However, after negative selection
with GCV, mutant LmaPA2G4 parasites retained the ectopic copy of
pXNG-PA2G4, as shown by the minimal reduction in GFP intensity
(Fig. 3C, lower panel). These results suggest that LmaPA2G4 is an
essential gene in L. major.
Phenotypic characterization of GFP-PA2G4 parasites
Since the essentiality of LmaP2G4 precluded further loss-of-
function analysis, we followed a gain-of-function strategy to reveal
the implication of LmaPA2G4 in the biology of Leishmania. We
created parasites over-expressing an N-terminal GFP-PA2G4
fusion protein. LmaPA2G4 ORF was cloned into pXG-GFP2+
as previously described [20]. We confirmed the fusion by western
blot analysis of L. major FVI wild-type (WT) and transgenic GFP-
PA2G4 promastigotes using monoclonal anti-GFP and tubulin as
a loading control (Fig. 4A). Fluorescence intensity of GFP-PA2G4
parasites was measured by flow cytometry (Fig. 4B). Live log-phase
transgenic promastigotes were immobilized on poly(l)lysine-coated
35 mm glass bottom dishes and cells were analyzed using spinning
disk confocal microscopy (Fig. 4C). Nuclei were counterstained
with NucBlue Live Cell stain (Molecular Probes) (red). The ectopic
expression of LmaPA2G4 is predominantly cytoplasmic and the
overexpression had no effect on the morphology and viability of
the parasites. Growth curves of WT, GFP-PA2G4 and GFP-mock
control show that the overexpression of LmaPA2G4 results in a
significant growth delay (Fig. 4D). LmaPA2G4 growth defect was
reproduced by transgenic parasites expressing untagged protein
(pLEXSY-PA2G4) and thus is independent from GFP expression.
We also analyzed the infective metacyclic stage in control and
transgenic lines. Similar numbers of metacyclic parasites were
agglutinated in both lines (Fig. 4E), indicating that the over-
expression of LmaPA2G4 does not affect metacyclogenesis.
GFP-PA2G4 transgenic parasites are attenuated in
virulence
We investigated the effects of LmaPA2G4 overexpression on
parasite virulence using an established experimental mouse
infection [29]. Mock, GFP-PA2G4 and cured GFP-PA2G4*
parasites grown in G418-free medium were normalized for
virulence through one passage in BALB/c mice [30]. 105 mock,
GFP-PA2G4 and GFP-PA2G4* metacyclic parasites were inocu-
lated into the hind footpad of groups of five female BALB/c mice.
Lesion formation was followed by measuring the increase in footpad
size with a Vernier caliper. Mock and GFP-PA2G4* parasites
elicited a strong response ca. 30 days after inoculation and resulted
in necrotic lesions (Fig. 5A). Interestingly GFP-PA2G4 are highly
attenuated and lesions were only apparent after 40 days after
inoculation. The cured line, grown in the absence of G418, elicited
a response similar to GFP mock parasites, suggesting that the
specific expression of LmaPA2G4 is responsible for the attenuated
phenotype. At least two independent GFP-PA2G4 lines were used
to rule out potential discrepancies due to clonal variations. To
determine whether the overexpression of LmaPA2G4 affects the
differentiation from pro- to amastigotes, we established L. donovani
transgenic (GFP-PA2G4) lines that allow axenic amastigote
differentiation. 26105 promastigotes were inoculated in low pH
medium and 37uC to trigger differentiation [9]. We monitored the
axenic amastigotes 24 and 48 h after differentiation (Fig. 5B). As
judged by the expression of the amastigote-specific A2 protein
family [31], transgenic parasites carrying GFP-PA2G4 are bona fide
amastigotes at 48 h and no differences are observed when
compared with WT. This result suggests that the virulence
attenuation is potentially due to defects in cell proliferation.
2D-DIGE comparative proteomics analysis
To gain a better insight into the function of LmaPA2G4, we
quantitatively compared protein extracts from L. major GFP-PA2G4
and mock promastigotes of three independent biological repeats.
Protein samples were differentially labelled with CyDye fluors (GE
Healthcare) and separated by two-dimensional electrophoresis
(2DE) on IPG strips and polyacrylamide gels as previously described
[21]. A representative merged image of Cy5-labeled GFP-mock
(red) and Cy3-labeled GFP-PA2G4 (green) is shown (Fig. 6A). Gels
were scanned on a Typhoon FLA-9500 Imager and analyzed by
Delta2D v 4.3 (Decodon) software package. Figure 6B shows a
graphical representation of the expression profiles of mock (red) and
GFP-PA2G4 (green) samples. Five spots with significant expression
differences in GFP-PA2G4 (p-value,0.005) were selected. Gels
were stained with the fluorescent stain SYPRO Ruby and the five
spots of interest were excised and identified by MS/MS. Interest-
ingly, the homologs of identified eukaryotic translation initiation
factor 5 (LmjF25.0720, 6.1-fold change), 60S ribosomal protein
(LmjF29.2460, 5.9-fold change) and 40S ribosomal protein
(LmjF28.0960, 5.3-fold change) are implicated in translation
initiation and elongation [32]. The chaperonin HSP60
(LmjF36.2030, 4.4-fold change) is involved in stress response and
acts as a catalyst of folding proteins [33]. Raw data of protein
identification and Mascot searches is presented in Table S1.
Electrophoretic Mobility Shift Assays (EMSA)
dsRNA-binding domains characterize an expanding family of
proteins involved in different cellular processes, ranging from
RNA editing and processing to translational control. Human
homolog Ebp1 interacts with double stranded RNA [34] and thus
it was tempting to study whether GFP-PA2G4 is able to bind a
synthetic double stranded RNA Poly (I:C). RNA molecules
(Sigma) were labeled with Cy5 in order to normalize and visualize
aminopeptidases 1 and 2 (METAP1 and 2), and non-peptidases. Alignment was fed into MEGA5.2 software and a Neighbor-Joining tree was
computed with 500 bootstrap replicates. Numbers on nodes indicate bootstrap support.
doi:10.1371/journal.pntd.0002646.g002
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the reaction. 40 ng labeled Poly(I:C) was incubated with 20 ng
GFP-PA2G4 protein in binding buffer at room temperature for
45 min and resolved on 10% non-denaturing polyacrylamide gels
in 16TBE. Gel was scanned in a Typhoon imager (GE) with Cy5
filters. Poly (I:C) is visible in lanes 1 and 3 (Fig. 7, left panel). Cy5
filters produce a non-specific background signal with xylene
cyanol, which is part of the loading buffer. Taking advantage of
the GFP fusion, the gel was re-scanned with a GFP filter, and
arrows indicate the apparent mobility shift of GFP-PA2G4 in the
presence of Poly (I:C) (Fig. 7, right panel).
De novo protein synthesis in parasites over-expressing
LmaPA2G4
The results from last section suggest a defect in protein
translation in transgenic parasites, potentially due to the non-
physiological accumulation of intermediates of translation initia-
tion and elongation. In order to confirm this phenotype, we
measured de novo protein synthesis in the transgenic lines.
Metabolic labeling of de novo synthetized proteins was conducted
using a non-radioactive assay. Mid-log L. major WT and GFP-
PA2G4 promastigotes as well as L. donovani WT and GFP-PA2G4
amastigotes were initially incubated in methionine-free medium.
Metabolic labeling was performed for 2 h at 27uC in the presence
of azidohomoalanine (AHA). A culture of L. major treated for 2 h
with 100 mg/mL cycloheximide, an inhibitor of protein biosyn-
thesis, was included as a positive control. After labeling, cells were
harvested, lysed and subjected to the Click-iT (Life) reaction with
TAMRA. Proteins were resolved in polyacrylamide gels and
visualized in a Typhoon FLA 9500 imager and fluorescence
measured with ImageQuant TL software (GE Healthcare). The
gel was then fixed and stained with SYPRO Ruby in order to
assess total protein content (Fig. 8). Percentage of de novo protein
synthesis is shown normalized to the controls L. donovani and L.
major WT parasites (Fig. 8, lower panel). These data suggest than
indeed de novo protein synthesis is greatly reduced in pro- and
amastigotes over-expressing LmaPA2G4. Defects in biosynthesis
will likely impact cell proliferation and ultimately may be
responsible for the phenotype observed.
Discussion
LmaPA2G4 is a homolog of the proliferation-associated 2G4
protein [35] also termed Ebp1 [14]. The human counterparts are
Figure 3. Establishment of L. major PA2G4 conditional null-mutant parasites. (A) Schematic representation of the null-mutant strategy.
Two alleles of LmaPA2G4 were replaced by homologous recombination with hygromycin B (HYG B) and puromycin (PAC) resistance markers.
Replacement was performed in the presence of an ectopic copy of PA2G4 (pXNG- PA2G4), carrying a nourseothricin (SAT) marker, a fluorescent
protein (GFP) and a Herpes simplex virus thymidine kinase (TK). (B) PCR analysis of total DNA from wild-type (WT) parasites or one independent clone
(PA2G4 2/2 [pXNG-PA2G4]). F1,R1 primers (expected size 338 bp) confirm the presence of the endogenous copy of PA2G4, while F2,R1 primers
(expected size 513 bp) confirm of the episomal PA2G4 ORF. F1, R2 primer pair (expected size 413 bp) and F1, R3 (expected size 440 bp) show the
integration of hygromycin b and puromycin genes, respectively. Molecular weight marker (M) is shown. (C) (Upper panel). WT parasites carrying a
copy of pXNG-PA2G4 were selected and grown in SAT and the GFP intensity was analyzed by flow cytometry (GCV2). After negative selection with
the addition of 50 mg/mL GCV (GCV+) to the culture (3 passages) a reduction in GFP fluorescence is observed (lower panel). In contrast, conditional
PA2G4 null-mutant parasites retained the ectopic copy of pXNG-PA2G4 as shown by the minimal reduction in GFP intensity. Histograms plots of one
representative analysis are shown. Dotted lines correspond to fluorescence background levels of control parasites.
doi:10.1371/journal.pntd.0002646.g003
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involved in the regulation of cell growth and differentiation [36].
Human homolog Ebp1 is a target for phosphorylation by PKC in
vitro and in vivo, and its C-terminus has been suggested to harbor
the phosphorylation site [37]. Furthermore, serine 363 (S363) of
Ebp1 is phosphorylated in vivo and the S363A mutation
significantly decreased the ability of Ebp1 to repress transcription
and abrogated its ability to inhibit cell growth [38]. LmaPA2G4
was isolated through a phospho-enrichment procedure (IMAC),
suggesting it may be a phosphoprotein. We are currently
characterizing the potential phosphorylated residues in Lma-
PA2G4 with a combination of IMAC enrichment and 2D LC-
MS/MS.
LmaPA2G4 is a metallopeptidase of the M24A family, clan MG
(Fig. 2). Bio-informatics analysis and multiple alignment identified
members of this family across all trypanosomatids, with a
remarkable conservation. The crystal structure of the human
PA2G4 has been determined at 1.6 A˚ resolution [13]. The
structure revealed a pita-bread fold conserved in methionine
Figure 4. Gain-of-function strategy to study LmaPA2G4. (A) WT or parasites over-expressing an N-terminal GFP-PA2G4 fusion protein were
lysed, resolved by SDS–PAGE, electroblotted on a PVDF membrane and analyzed by western blot using monoclonal anti-GFP antibody and anti-
tubulin as a loading control. The molecular weight of standard proteins is indicated in kDa. (B) GFP intensity in GFP-PA2G4 transgenic promastigotes
was analyzed in a Beckman Coulter FC-500 flow cytometer. 10,000 events were recorded. GFP mock control parasites are clearly distinguished from
GFP-PA2G4. (C) Live control and transgenic promastigotes from logarithmic culture were analyzed using spinning disk confocal microscopy. Nuclei
were counterstained with 1 mg/mL NucBlue Live Cell stain (Molecular Probes) (red). The bar corresponds to 7 mm. (D) Growth curve of L. major WT,
GFP-mock, GFP-PA2G4, pLEXSY and pLEXSY-PA2G4 promastigotes was measured microscopically by counting cells in a Neubauer chamber. The
average and standard deviation of triplicate determinations are shown. (E) The infective metacyclic stage in control and transgenic lines was analyzed.
Parasites from five day stationary cultures were incubated with peanut agglutinin and numbers of non-agglutinating metacyclics were determined
microscopically. Two independent experiments were performed and one representative triplicate experiment with standard deviation denoted by
the bars is shown.
doi:10.1371/journal.pntd.0002646.g004
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aminopeptidases (MetAPs). In these enzymes, a divalent metal
center within the catalytic site is involved in the cleavage of the
appropriate substrate. However, the metal ions are not present in
PA2G4 [13], and therefore no enzymatic activity can be
performed. This group of enzymes are reflected in MEROPS
database as non-peptidase members of the M24 family. Lma-
PA2G4 is well conserved among trypanosomatids, indicating an
essential function and selection pressure despite having lost its
Figure 5. Attenuated virulence in GFP-PA2G4 transgenic parasites. (A) 105 L. major metacyclic mock and transgenic parasites expressing
GFP-PA2G4 and cured GFP-PA2G4 grown in the absence of G418 were inoculated into the footpad of female BALB/c mice. Lesion formation was
followed by measuring the increase in footpad size with a Vernier caliper. Groups of five mice were analyzed and standard deviation is indicated by
the bars. Two independent experiments were performed and one representative experiment is shown. (B) L. donovani transgenic (GFP-PA2G4) lines
were established. 26105 promastigotes were inoculated in low pH medium and 37uC to trigger differentiation to axenic amastigotes. Cells were lysed
24 and 48 h after differentiation, and western blot performed with anti-GFP, amastigote-specific A2 antibody and anti-tubulin as a loading control.
The molecular weight of standard proteins is indicated in kDa.
doi:10.1371/journal.pntd.0002646.g005
Figure 6. 2D-DIGE analysis of the L.major mock and GFP-PA2G4 proteome. (A) Representative 2D-DIGE gel. Protein extracts from
promastigotes of three independent biological experiments were differentially labeled with the CyDye fluors Cy3, Cy5 and Cy2, and separated by
two-dimensional electrophoresis on 13 cm pH 4–7 IPG strips and 12.5% polyacrylamide gels. Gels were scanned on a Typhoon FLA 9500 (GE
Healthcare) imager. A merged image of Cy5-labeled GFP-mock (red) and Cy3-labeled GFP-PA2G4 (green) is shown. The molecular weight of marker
proteins and the pI range of the IEF gradient are indicated. (B) Differences in protein abundance were revealed by analyzing the gel images with
Delta2D v4.3 software (Decodon). Histograms are a graphic representation of these significant differences. For normalization purposes, a Cy2-labeled
internal standard was included, corresponding to a pool of protein from all extracts used in the analysis (yellow bars). Fold change and p-values of the
spots selected are shown, as well as protein identification by mass spectrometry. Raw data of MS data and Mascot searches is presented in Table S1.
doi:10.1371/journal.pntd.0002646.g006
Essential Genes as Drug Targets in Leishmania
PLOS Neglected Tropical Diseases | www.plosntds.org 9 January 2014 | Volume 8 | Issue 1 | e2646
catalytic site. Further substrate binding studies are necessary to
conclusively label LmaPA2G4 as a pseudoenzyme. Inactive
enzyme homologs are not simply debris and functional studies,
for instance in the iRhom family of rhomboid proteases, have
revealed important roles as biological regulators [39]. With the
exception of pseudokinases, there is still a lack of functional
information on the roles of inactive enzymes [40].
We have confirmed that LmaPA2G4 is an essential gene in L.
major. Study of some promising candidate genes through loss-of-
function is often hindered by lethal mutant phenotypes and our
system (Fig. 3A) allows to test whether the guarding episome
(pXNG) can be actively and quickly removed in the null mutant
(Fig. 3C). Moreover, it indicates that the loss of LmaPA2G4
cannot be compensated by other related genes. Our findings may
be applicable to other trypanosomatids, however viability of the
LmaPA2G4 null mutant must be carefully examined in Trypano-
soma and other Leishmania spp.
The overexpression of LmaPA2G4 did not impair the ability of
L. major to differentiate into infective metacyclic promastigotes
(Fig. 4D) and L. donovani promastigotes were able to fully
differentiate into axenic amastigotes within 48 h (Fig. 5B). These
data suggest that the attenuated virulence observed in the murine
model (Fig. 5A) is likely due to a defect in proliferation. To better
understand this phenotype, we performed quantitative proteomics
Figure 7. Electrophoretic Mobility Shift Assay. Poly (I:C), a
synthetic double stranded RNA was labeled with Cy5 and incubated
with 20 ng GFP-PA2G4 fusion protein at room temperature for 45 min.
The reaction was resolved in 10% non-denaturing polyacrylamide gels.
Lane 1: 40 ng poly (I:C); lane 2: 20 ng GFP-PA2G4; lane 3: 20 ng GFP-
PA2G4 incubated with 40 ng poly (I:C). Gel was scanned on a Typhoon
scanner (GE) using 633/670 nm for Cy5 and 489/508 nm for GFP.
Arrows indicate mobility shift of GFP-PA2G4.
doi:10.1371/journal.pntd.0002646.g007
Figure 8. Over-expression of PA2G4 leads to a reduced de novo protein synthesis. Metabolic labeling of de novo synthetized proteins was
conducted using a non-radioactive Click-iT (Life) assay. Mid-log L. major WT and GFP-PA2G4 promastigotes (pro) and L. donovani WT and GFP-PA2G4
amastigotes (ama) were used in the experiment. Metabolic labeling was performed for 2 h at 27uC in presence of 50 mM azidohomoalanine (AHA). A
culture of L. major treated for 2 h with 100 mg/mL cycloheximide, an inhibitor of protein biosynthesis, was included as a positive control.
Fluorescence signal from TAMRA (Life) was measured to determine de novo protein synthesis. Gels were then stained with SYPRO Ruby (Molecular
Probes) to quantify the signal of total protein synthesis. Fluorescence intensities are plotted as arbitrary units of fluorescence (AUF). Two independent
experiments were performed and one representative triplicate experiment with standard deviation is shown. Percentage of de novo synthesis
normalized to WT values is shown in the lower panel. Median values were used for non-parametric Mann–Whitney U-test.
doi:10.1371/journal.pntd.0002646.g008
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that allowed us to study significant differences in protein
expression as a result of LmaPA2G4 overexpression (Fig. 6A
and B). 2D DIGE has proven to circumvent the limitation of
traditional in-gel proteomics, especially when combined with
bottom-up proteomics [41]. The most over-represented 26.1 fold
change- spot corresponds to the eukaryotic elongation factor 5A.
eIF5A is the only protein that contains the modified amino acid
hypusine [42]. Hypusine is formed in eIF5A by post-translational
modification of one of the lysyl residues in two consecutive steps
through the action of deoxyhypusine synthase (DHS) and
deoxyhypusine hydroxylase (DOHH) [43]. The hypusine pathway
is conserved in trypanosomatids, and DHS and DOHH have been
recently characterized in T. brucei [44] and L. donovani [45],
respectively. In higher eukaryotes, eIF5A has an active role in
translation elongation, however its precise requirement in protein
synthesis remains elusive [46]. 60S and 40S ribosomal subunits
showed a 5.9 and 5.3 fold change respectively in promastigotes
over-expressing LmaPA2G4. In higher eukaryotes, translation
initiation starts with the disassociation of the 80S ribosomal
complex and the binding of eIF6 to the 60S ribosomal subunit and
the binding of eIF3 and eIF1A to the 40S ribosomal subunit [47].
The HSP60 family of chaperonines 24.4 fold change in our
analysis- are widely present in trypanosomatids and they have a
potential role in folding of proteins imported into the mitochon-
dria [48]. It is noteworthy that our proteomic approach does not
allow us to confirm any potential interaction of LmaPA2G4 with
the key transcription elements discussed above. The EMSA assay
suggests that GFP-PA2G4 binds a generic and synthetic double
stranded RNA (Fig. 7). It is tempting to speculate that further
investigations on the RNA binding domains will allow us to gain
insight on the biological relevance of binding on, for instance,
translational control. The fact the de novo protein synthesis is
significantly reduced in the transgenic lines (Fig. 8) and the new
insights on transcriptional roles of the human counterpart [49]
suggest a potential role of LmaPA2G4 in transcription in L. major.
Altered transcription in lines over-expressing LmaPA2G4 lines
leads to defects in cell growth, including the pathogenic amastigote
stage. However, further investigation is required to dissect the
molecular mechanisms in which LmaPA2G4 is involved. In
conclusion, this work underscores its essential role in the biology of
the parasite and opens new venues for potential therapeutic
intervention.
Supporting Information
Figure S1 In vitro kinase assay. GFP-PA2G4 and GFPK7
immuno-precipitates were isolated from stationary promastigotes.
Phosphotransferase activity was determined by autoradiography.
Molecular weight is indicated in kDa. A replica gel was analyzed
by western blot using monoclonal GFP antibody. Lane 1: GFP7
incubated with GFP-PA2G4 as a substrate; lane 2: GFPK7
incubated with 3 mg MBP; lane 3: GFP-PA2G4 immuno-complex;
lane 4: GFPK7 immuno-complex.
(TIF)
Figure S2 RT-PCR analysis of PA2G4 transcript levels.
Total RNA was isolated from L. major logarithmic (l) and met
acyclic (m) promastigotes and from L. donovani logarithmic (l)
promastigotes and (a) amastigotes. After cDNA synthesis, PCR
was performed with specific primers for PA2G4 and GAPDH.
Products were resolved in 1% agarose gels, stained with SybrSafe
(Life) and scanned on a Typhoon FLA 9500 imager. Band
intensities were analyzed with ImageQuant TL (GE Healthcare)
and PA2G4 expression was normalized to GAPDH signal.
Reactions without RT were used a negative control. Three
independent reactions were carried and standard deviations are
shown.
(TIF)
Table S1 Raw data of mass spectrometry identification
and Mascot and/or Protein Pilot searches.
(PDF)
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